Literature DB >> 7917920

Prevalence of human papillomavirus DNA sequences in an area with very high incidence of cervical carcinoma.

C C Pao1, S M Kao, G C Tang, K Lee, J Si, S Ruan.   

Abstract

To improve our understanding of the relationship and possible associations between human papillomavirus (HPV) infection and the development of cervical malignancies, the presence of multiple types of HPV DNA sequences in cervical carcinoma was determined in Chinese citizens living in two different geographical locations where the incidences of cervical carcinoma are either relatively low or extremely high. HPV DNA sequences were found in 88.5% (54 of 61) of Chinese cervical carcinoma patients living in Taiwan, where the prevalence of cervical carcinoma is 23.7 per 100,000 women. In contrast, in LueYang in Shanxi province, an area with a very high prevalence of cervical carcinoma (1,026 per 100,000 women), only 57.1% (28 of 49) of Chinese cervical carcinoma patients were found to be infected with genital HPV. This result seems to suggest that either the presence of HPV may have different implications in different populations or HPV infection may not be the only factor that determines the development of cervical carcinoma, at least in certain geographical areas. Recently acquired transient or chronic persistent HPV infection may have a different outcome with regard to cervical carcinogenesis. Alternatively, other factors, such as host determinants, may play a role in the development of cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917920      PMCID: PMC2033425          DOI: 10.1038/bjc.1994.375

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

Review 1.  Papillomaviruses and human cancer.

Authors:  M J Arends; A H Wyllie; C C Bird
Journal:  Hum Pathol       Date:  1990-07       Impact factor: 3.466

Review 2.  Human papillomaviruses and genital cancer.

Authors:  H Pfister
Journal:  Adv Cancer Res       Date:  1987       Impact factor: 6.242

3.  Papillomavirus DNA in cervical carcinoma specimens from central China.

Authors:  X Xiao; M Cao; T R Miller; Z Y Cao; T S Yen
Journal:  Lancet       Date:  1988-10-15       Impact factor: 79.321

Review 4.  The role of human papillomaviruses in the pathogenesis and histologic classification of precancerous lesions of the cervix.

Authors:  R J Brescia; A B Jenson; W D Lancaster; R J Kurman
Journal:  Hum Pathol       Date:  1986-06       Impact factor: 3.466

5.  The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection.

Authors:  L S Young; I S Bevan; M A Johnson; P I Blomfield; T Bromidge; N J Maitland; C B Woodman
Journal:  BMJ       Date:  1989-01-07

6.  Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells.

Authors:  C C Pao; S S Lin; C Y Lin; J S Maa; C H Lai; T T Hsieh
Journal:  Am J Clin Pathol       Date:  1991-04       Impact factor: 2.493

7.  Genital human papillomavirus infection in female university students as determined by a PCR-based method.

Authors:  H M Bauer; Y Ting; C E Greer; J C Chambers; C J Tashiro; J Chimera; A Reingold; M M Manos
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

8.  Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes.

Authors:  A Schneider-Gädicke; E Schwarz
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

9.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

Authors:  P Hawley-Nelson; K H Vousden; N L Hubbert; D R Lowy; J T Schiller
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

10.  Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)--a second look.

Authors:  S K Kjaer; E M de Villiers; H Cağlayan; E Svare; B J Haugaard; G Engholm; R B Christensen; K A Møller; P Poll; H Jensen
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

View more
  2 in total

1.  Evaluation of microRNAs as potential biomarkers in circulating HPV-DNA-positive non-small cell lung cancer patients.

Authors:  Yao Wu; Qing Yin; Ya-Ling Zhou; Lei He; Zhi-Qing Zou; Xiao-Yue Dai; Wen Xia
Journal:  Cancer Biol Ther       Date:  2021-02-04       Impact factor: 4.742

2.  TP53 R72P Polymorphism and Susceptibility to Human Papillomavirus Infection Among Women With Human Immunodeficiency Virus in Morocco: A Case-control Study.

Authors:  Ahd Oulad Lahsen; Hanâ Baba; Rajaa Bensghir; Naouar Fayssel; Mustapha Sodqi; Latifa Marih; Sellama Nadifi; Lahcen Wakrim; Kamal Marhoum El Filali; Sayeh Ezzikouri
Journal:  J Cancer Prev       Date:  2017-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.